GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » International Isotopes Inc (OTCPK:INIS) » Definitions » Gross Margin %

INIS (International Isotopes) Gross Margin % : 62.41% (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is International Isotopes Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. International Isotopes's Gross Profit for the three months ended in Sep. 2024 was $2.45 Mil. International Isotopes's Revenue for the three months ended in Sep. 2024 was $3.92 Mil. Therefore, International Isotopes's Gross Margin % for the quarter that ended in Sep. 2024 was 62.41%.


The historical rank and industry rank for International Isotopes's Gross Margin % or its related term are showing as below:

INIS' s Gross Margin % Range Over the Past 10 Years
Min: 38.28   Med: 48.67   Max: 63.12
Current: 63.12


During the past 13 years, the highest Gross Margin % of International Isotopes was 63.12%. The lowest was 38.28%. And the median was 48.67%.

INIS's Gross Margin % is ranked better than
76.06% of 969 companies
in the Drug Manufacturers industry
Industry Median: 47.02 vs INIS: 63.12

International Isotopes had a gross margin of 62.41% for the quarter that ended in Sep. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for International Isotopes was 4.90% per year.


International Isotopes Gross Margin % Historical Data

The historical data trend for International Isotopes's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Isotopes Gross Margin % Chart

International Isotopes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.10 58.30 59.39 56.25 60.15

International Isotopes Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.43 62.41 64.26 63.68 62.41

Competitive Comparison of International Isotopes's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, International Isotopes's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Isotopes's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, International Isotopes's Gross Margin % distribution charts can be found below:

* The bar in red indicates where International Isotopes's Gross Margin % falls into.



International Isotopes Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

International Isotopes's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=7.4 / 12.267
=(Revenue - Cost of Goods Sold) / Revenue
=(12.267 - 4.888) / 12.267
=60.15 %

International Isotopes's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=2.4 / 3.924
=(Revenue - Cost of Goods Sold) / Revenue
=(3.924 - 1.475) / 3.924
=62.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


International Isotopes  (OTCPK:INIS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

International Isotopes had a gross margin of 62.41% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


International Isotopes Gross Margin % Related Terms

Thank you for viewing the detailed overview of International Isotopes's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


International Isotopes Business Description

Traded in Other Exchanges
N/A
Address
4137 Commerce Circle, Idaho Falls, ID, USA, 83401
International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. Geographically, it generates the majority of its revenue from the United States.
Executives
W Matthew Cox officer: Chief Financial Officer C/O INTERNATIONAL ISOTOPES INC., 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Shahe Bagerdjian officer: President 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Christopher G Grosso director, 10 percent owner C/O KERSHNER GROSSO & CO, 480 BROADWAY, SARASOTA SPRINGS NY 12866
Robert Atcher director 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Laurie Mckenzie-carter officer: Chief Financial Officer 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Steve Laflin director, officer: Pres. & CEO 1258 E AIRPORT ROAD, BLACKFOOT ID 83221
William W Nicholson 10 percent owner 121 NORTH POST OAK LANE STE 2105, HOUSTON TX 77024
Ralph M Richard director, 10 percent owner 350 SHORE DRIVE, OAKDALE NY 11769
John M Mccormack 10 percent owner 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Walter D Ohearn other: Part of 13D group 1115 5TH AVENUE, NEW YORK NY 10128
Keane Marie C & Keane James Jtwros 10 percent owner